Screening for inhibitors against SARS-CoV-2 and its variants

Screening for inhibitors against SARS-CoV-2 and its variants

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to evolve, generating new variants that pose a threat to global health; therefore, it is imperative to obtain safe and broad-spectrum antivirals against SARS-CoV-2 and its variants. To this end, we screened compounds for their ab...

Full description

Bibliographic Details
Main Authors: Weijing Yuan, Xiaojing Dong, Lan Chen, Xiaobo Lei, Zhuo Zhou, Li Guo, Jianwei Wang
Format: Article
Language:English
Published: Elsevier 2022-06-01
Series:Biosafety and Health
Subjects:
SARS-CoV-2
Delta variant
Omicron variant
Trifluoperazine 2HCl
Thioridazine HCl
Antiviral therapy
Online Access:http://www.sciencedirect.com/science/article/pii/S2590053622000556

Internet

http://www.sciencedirect.com/science/article/pii/S2590053622000556

Similar Items